Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients

This study has been completed.
Information provided by:
Sanofi Identifier:
First received: July 26, 2002
Last updated: March 4, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2004
  Estimated Primary Completion Date: No date given